Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

Birdshot-like Chorioretinopathy Associated With Pembrolizumab Treatment.

Acaba-Berrocal LA, Lucio-Alvarez JA, Mashayekhi A, Ho AC, Dunn JP, Shields CL.

JAMA Ophthalmol. 2018 Jul 26. doi: 10.1001/jamaophthalmol.2018.1851. [Epub ahead of print] No abstract available.

PMID:
30054605
2.

INTRAVITREAL MELPHALAN FOR TREATMENT OF VITREOUS SEEDING FROM CHOROIDAL MELANOMA.

Masoomian B, Mashayekhi A, Malik K, Shields CL.

Retin Cases Brief Rep. 2018 Jul 25. doi: 10.1097/ICB.0000000000000798. [Epub ahead of print]

PMID:
30048404
3.

MULTIMODAL IMAGING OF MACULAR CHOROIDAL MACROVESSEL: A REPORT OF TWO CASES.

Dalvin LA, Pennington JD, Mashayekhi A, Shields CL.

Retin Cases Brief Rep. 2018 Jul 13. doi: 10.1097/ICB.0000000000000776. [Epub ahead of print]

PMID:
30015777
4.

GROWTH OF PRESUMED CHOROIDAL NEVUS INTO MELANOMA OVER 4 YEARS IN BAP1 TUMOR PREDISPOSITION SYNDROME.

Masoomian B, Shields CL, Mashayekhi A, Ganguly A, Shields JA.

Retin Cases Brief Rep. 2018 Jul 6. doi: 10.1097/ICB.0000000000000772. [Epub ahead of print]

PMID:
29994997
5.

Cytogenetic results of choroidal nevus growth into melanoma in 55 consecutive cases.

Shields CL, Pefkianaki M, Mashayekhi A, Shields JA, Ganguly A.

Saudi J Ophthalmol. 2018 Jan-Mar;32(1):28-32. doi: 10.1016/j.sjopt.2018.02.004. Epub 2018 Feb 15.

6.

PHOTODYNAMIC THERAPY AS PRIMARY TREATMENT FOR SMALL CHOROIDAL MELANOMA.

Turkoglu EB, Pointdujour-Lim R, Mashayekhi A, Shields CL.

Retina. 2018 Apr 13. doi: 10.1097/IAE.0000000000002169. [Epub ahead of print]

PMID:
29659412
7.

By Sleight of Hand, Prognosis Determined-Even for Small Choroidal Melanoma.

Shields CL, Mashayekhi A, Shields JA.

JAMA Ophthalmol. 2018 May 1;136(5):488-489. doi: 10.1001/jamaophthalmol.2018.0196. No abstract available.

PMID:
29596557
8.

LARGE UVEAL MELANOMA (≥10 MM THICKNESS): Clinical Features and Millimeter-by-Millimeter Risk of Metastasis in 1311 Cases. The 2018 Albert E. Finley Lecture.

Shields CL, Sioufi K, Robbins JS, Barna LE, Harley MR, Lally SE, Say EAT, Mashayekhi A, Shields JA.

Retina. 2018 Mar 8. doi: 10.1097/IAE.0000000000002144. [Epub ahead of print]

PMID:
29528980
9.

Intravitreal Aflibercept as Rescue Therapy for Post-Radiation Cystoid Macular Edema Resistant to Intravitreal Bevacizumab: Outcomes at 1 Year.

Khan MA, Mashayekhi A, Shields JA, Shields CL.

Ocul Oncol Pathol. 2017 Nov;3(4):313-319. doi: 10.1159/000452163. Epub 2017 May 6.

10.

High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular Edema.

Khan MA, Mashayekhi A, Ferguson K, Shields JA, Shields CL.

Ocul Oncol Pathol. 2017 Sep;3(3):168-175. doi: 10.1159/000448719. Epub 2017 Jan 27.

11.

Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture.

Shields CL, Roelofs K, Di Nicola M, Sioufi K, Mashayekhi A, Shields JA.

Indian J Ophthalmol. 2017 Nov;65(11):1093-1104. doi: 10.4103/ijo.IJO_752_17.

12.

Intravitreal Melphalan for Treatment of Primary Vitreoretinal Lymphoma: A New Indication for an Old Drug.

Shields CL, Sioufi K, Mashayekhi A, Shields JA.

JAMA Ophthalmol. 2017 Jul 1;135(7):815-818. doi: 10.1001/jamaophthalmol.2017.1810. No abstract available.

PMID:
28617918
13.

Congenital Hypertrophy of Retinal Pigment Epithelium With Overlying Thin Adenoma.

Pefkianaki M, Mashayekhi A, Shields JA, Shields CL.

Retina. 2017 Jun;37(6):e69-e70. doi: 10.1097/IAE.0000000000001483. No abstract available.

PMID:
28541252
14.

Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.

Shields CL, Say EAT, Hasanreisoglu M, Saktanasate J, Lawson BM, Landy JE, Badami AU, Sivalingam MD, Hauschild AJ, House RJ, Daitch ZE, Mashayekhi A, Shields JA, Ganguly A.

Ophthalmology. 2017 Oct;124(10):1523-1531. doi: 10.1016/j.ophtha.2017.04.003. Epub 2017 May 7.

PMID:
28495150
15.

Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture.

Shields CL, Say EAT, Hasanreisoglu M, Saktanasate J, Lawson BM, Landy JE, Badami AU, Sivalingam MD, Mashayekhi A, Shields JA, Ganguly A.

Ophthalmology. 2017 May;124(5):609-618. doi: 10.1016/j.ophtha.2016.12.026. Epub 2017 Jan 31.

PMID:
28159380
16.

COUGHING-INDUCED SUPRACHOROIDAL HEMORRHAGE SIMULATING MELANOMA IN TWO CASES.

Marous CL, Sioufi K, Shields CL, Mashayekhi A, Shields JA.

Retin Cases Brief Rep. 2018 Fall;12(4):336-341. doi: 10.1097/ICB.0000000000000502.

PMID:
27893592
17.

PHOTODYNAMIC THERAPY FOR CHOROIDAL NEVUS WITH SUBFOVEAL FLUID.

Pointdujour-Lim R, Mashayekhi A, Shields JA, Shields CL.

Retina. 2017 Apr;37(4):718-723. doi: 10.1097/IAE.0000000000001202.

PMID:
27433882
18.

Assessment of CTLA-4 Deficiency-Related Autoimmune Choroidopathy Response to Abatacept.

Shields CL, Say EA, Mashayekhi A, Garg SJ, Dunn JP, Shields JA.

JAMA Ophthalmol. 2016 Jul 1;134(7):844-6. doi: 10.1001/jamaophthalmol.2016.1013. No abstract available.

PMID:
27258812
19.

EXTERNAL BEAM RADIATION FOR CHOROIDAL LYMPHOMA: Efficacy and Complications.

Mashayekhi A, Hasanreisoglu M, Shields CL, Shields JA.

Retina. 2016 Oct;36(10):2006-12. doi: 10.1097/IAE.0000000000001026.

PMID:
27031528
20.

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE MACULA AFTER PLAQUE RADIOTHERAPY OF CHOROIDAL MELANOMA: Comparison of Irradiated Versus Nonirradiated Eyes in 65 Patients.

Shields CL, Say EA, Samara WA, Khoo CT, Mashayekhi A, Shields JA.

Retina. 2016 Aug;36(8):1493-505. doi: 10.1097/IAE.0000000000001021.

PMID:
26960015

Supplemental Content

Loading ...
Support Center